How significant are environmental estrogens to women?

References

• Turner K. J., Sharpe R. M. Environmental estrogens - present understanding. Rev Reprod. 1997; 2: 69–73
   PubMedGoogle Scholar
• Sharpe R. M., Skakkebaek N. E. Are estrogens involved in falling sperm counts and disorders in the male reproductive tract?. Lancet 1993; 341: 1392–5
   PubMed Web of Science ®Google Scholar
• Toppari J., Larsen J. C., Christiansen C., et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996; 104(Suppl 4)741–803
   PubMed Web of Science ®Google Scholar
• Wolff M. S., Toniolo P. G., Leel E. W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 1993; 85: 648–52
   PubMed Web of Science ®Google Scholar
• Cassidy A. Physiological effects of phytoestrogens in relation to cancer and other human health risks. Proc Nutr Soc. 1996; 55: 399–417
   PubMed Web of Science ®Google Scholar
• Miksicek R. J. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol. 1993; 44: 37–43
   PubMed Web of Science ®Google Scholar
• Gehm B. D., McAndrews J. M., Chien P. Y., Jameson J. L. Resveratrol, a polyphenols compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997; 94: 14138–43
   PubMed Web of Science ®Google Scholar
• Jobling S., Reynolds T., White R., Parker M. G., Sumpter J. P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly oestrogenic. Environ Health Perspect. 1995; 103: 582–7
   PubMed Web of Science ®Google Scholar
• Guillette LJ, Jr, Arnold S. F., McLachlan J. A. Ecosystems and embryos - is there a scientific basis for concern?. Anim Reprod Sci 1996; 42: 13–24
   Web of Science ®Google Scholar
• Soto A. M., Lin T. M., Justica H., Silvia R. M., Sonnenschein C. An ‘in culture’ bioassay to assess the estrogenicity of xenobiotics: E-screen. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection, T. Colborn, C. Clements. Princeton Scientific Publishing Co., Princeton, NJ 1992; 295–309
   Google Scholar
• Routledge E. J., Sumpter J. P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem. 1996; 15: 241–58
   Web of Science ®Google Scholar
• White R., Jobling S., Hoare S. A., Sumpter J. P., Parker M. G. Environmentally persistent alkyl-phenolic compounds are estrogenic. Endocrinology 1994; 135: 175–82
   PubMed Web of Science ®Google Scholar
• Milligan S. R., Balasubramanian A. V., Kalita J. C. Relative potency of xenobiotic oestrogens in an acutein vivo, mammalian assay. Environ Health Perspect. 1998; 106: 23–6
   PubMed Web of Science ®Google Scholar
• Martin L., Pollard J. W., Fagg B. Oestriol, oestradiol 17β and the proliferation and death of uterine cells. J Endocrinol 1976; 69: 103–15
   PubMedGoogle Scholar
• Kuiper GGJM, Enmark E., Peltohuikki M., Nilsson S., Gustaffson J. A. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; 93: 5925–30
   PubMed Web of Science ®Google Scholar
• Paech K., Webb P., Kuiper GGJM, et al. Differential ligand activation of estrogen receptors ERa and ERβ at API sites. Science 1997; 277: 1508–10
   PubMed Web of Science ®Google Scholar
• Kuiper GGJM, Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997; 138: 863–70
   PubMed Web of Science ®Google Scholar
• Kuiper GGJM, Nilsson S., Gustaffson J. A. Characteristics and function of the novel estrogen receptor p. Hormones and Signalling, B. W. O'Malley. Academic Press, New York 1998; 1: 89–112
   Google Scholar
• Tetsuka M., Anderson R. A., Hillier S. G. Distribution of messenger RNA's encoding oestrogen receptor isoforms in female reproductive tissues. J Endocrinol 1997; 152(Suppl)20
   Google Scholar
• Brandenberger A. W., Tee M. K., Lee J. Y., Chao V., Jaffe R. B. Tissue distribution of estrogen receptors α (ERα) and β (ERβ) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997; 82: 3509–12
   PubMed Web of Science ®Google Scholar
• Cowley S. M., Hoare S., Mosselman S., Parker M. G. Estrogen receptors α and β form hetero-dimers on DNA. J Biol Chem 1997; 272: 19858–62
   PubMed Web of Science ®Google Scholar
• Safe S., Krishnan V. Chlorinated hydrocarbons: estrogens and antiestrogens. Toxicol Lett. 1995; 82: 731–6
   PubMed Web of Science ®Google Scholar
• Krishnan V., Porter W., Santostefano M., Wang X., Safe S. Molecular mechanism of inhibition of estrogen induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF7 cells. Mol Cell Biol. 1995; 15: 6710–19
   PubMed Web of Science ®Google Scholar
• Tran D. Q., Klotz D. M., Ladlie B. L., Ide C. F., McLachlan J. A., Arnold S. F. Inhibition of progesterone receptor activity in yeast by synthetic chemicals. Biochetn Biophys Res Commun. 1996; 229: 518–23
   PubMed Web of Science ®Google Scholar
• Leblanc G. A., Bain L. J., Wilson V. S. Pesticides: multiple mechanisms of demasculinization. Mol Cell Endocrinol. 1997; 126: 1–5
   PubMed Web of Science ®Google Scholar
• Milligan S. R., Khan O., Nash M. Competitive binding of xenobiotic oestrogens to rat a fetoprotein and to sex steroid binding proteins in human and rainbow trout(Oncorhynchus mykiss)plasma. Gen Comp Endocrin 1998, in press
   PubMed Web of Science ®Google Scholar
• Wang C., Makela T., Hase T., Adlercreutz H., Kurzer M. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem. 1994; 50: 205–12
   Google Scholar
• Evans BAJ, Griffiths K., Morton M. S. Inhibition of 5a-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and iso-flavonoids. J Endocrinol 1995; 147: 295–302
   PubMed Web of Science ®Google Scholar
• Makela S., Poutanen M., Lehtimaki J., Kostian M. L., Santti R., Vihko R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens. Proc Soc Exp Biol Med. 1995; 208: 51–9
   PubMed Web of Science ®Google Scholar
• Pathak D., Pathak K., Singla A. K. Flavonoids as medicinal agents - recent advances. Fitoterapia. 1991; 62: 371–89
   Google Scholar
• Schubétt W., Eriksson U., Edgar B., Cullberg G., Hedner T. Flavonoids in grapefruit juice inhibit thein vitrometabolism of 17β-oestradiol. Eur J Drug Metab Pharmacokinetics. 1995; 20: 219–24
   PubMed Web of Science ®Google Scholar
• Divi R. L., Doerge D. R. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol. 1996; 9: 16–23
   PubMed Web of Science ®Google Scholar
• Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of rebonucleotide reductase. FEBS Lett. 1998; 421: 277–9
   PubMed Web of Science ®Google Scholar
• Belguendouz L., Fremont L., Gozzelino M. T. Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol. 1998; 55: 811–16
   PubMed Web of Science ®Google Scholar
• Adlercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-oestrogens in Japenese men. Lancet. 1993; 342: 1209–10
   PubMed Web of Science ®Google Scholar
• Wang TTY, Sathyamoorthy N., Phang J. M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996; 17: 271–5
   PubMed Web of Science ®Google Scholar
• McLnerney E. M., Tsai M. J., O'Malley B. W., Katzenellenbogen B. S. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA 1996; 93: 10069–73
   PubMed Web of Science ®Google Scholar
• Setchell KDR, Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. Role of the Gut Flora in Toxicity and Cancer, I.R. Rowland. Academic Press, London 1988; 315–45
   Google Scholar
• Ruh M. F., Zacharewsi T., Connor K., Howell J., Chen I., Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol. 1995; 50: 1485–93
   PubMed Web of Science ®Google Scholar
• Arnold S. F., Klotz D. M., Vonier P. M., Collins B. M., Guillette LJ, Jr, McLachlan J. A. Synergistic activation of human estrogen receptor by combinations of environmental chemicals. Science 1996; 272: 1489–92
   PubMed Web of Science ®Google Scholar
• Ramamoorthy K., Wang F., Chen I. C., et al. Potency of combined estrogenic pesticides [Letter]. Science 1997; 275: 405–6
   PubMed Web of Science ®Google Scholar
• Ashby J., Lefevre P. A., Odum J., Harris C. A., Routledge E. J., Sumpter JP. Synergy between synthetic estrogens?. Nature (London) 1997; 485: 494
   Google Scholar
• McLachlan JA. Synergistic effect of environmental estrogens: report withdrawn. Science 1997; 277: 459
   PubMedGoogle Scholar
• Setchell KDR. Overview of isoflavone structure, metabolism and pharmacokinetics. Am J Clin Nutr 1998, in press
   Google Scholar
• Safe S. H. Environmental and dietary estrogens and human health: is there a problem?. Environ Health Persp 1995; 103: 346–51
   PubMed Web of Science ®Google Scholar
• Jones A. E., Price K. R., Fenwick G. R. Development and application of a HPLC method for the analysis of phytoestrogens. J Sci Food Agr. 1989; 46: 357–64
   Web of Science ®Google Scholar
• Nagata C., Takatsuka N., Kurisu Y., Shimizu H. Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women. J Nutr 1998; 128: 209–13
   PubMed Web of Science ®Google Scholar
• Thompson L. U., Robb P., Serraino M., Cheug F. Mammalian lignan production from various foods. Nutr Cancer. 1991; 16: 43–52
   PubMed Web of Science ®Google Scholar
• Adlercreutz H., Fotsis T., Bannwart C., et al. Determination of urinary lignans and phytoestrogen metabolites, potential antioestrogens and anticarcinogens, in the urine of women on various habitual diets. J Steroid Biochem 1986; 25: 791–7
   PubMedGoogle Scholar
• Cassidy A. Plant oestrpgens and their relation to hormonal status in women. PhD thesis. Cambridge University. 1991
   Google Scholar
• Cassidy A., Bingham S., Setchell K. Biological effects of isoflavones present in soy in premenopausal women: implications for the prevention of breast cancer. Am J Clin Nutr. 1994; 60: 333–40
   PubMed Web of Science ®Google Scholar
• Cassidy A., Bingham S., Setchell K. Biological effects of isoflavones in young women - importance of the chemical composition of soya products. Br J Nutr. 1995; 74: 587–601
   PubMed Web of Science ®Google Scholar
• Xu X., Wang H. J., Murphy P. A., Cook L., Henrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994; 124: 825–32
   PubMed Web of Science ®Google Scholar
• Setchell KDR, Bordello S. P., Hulme P., Kirk D. N., Axelson M. Non-steroidal oestrogens of dietary origin: possible roles in hormone dependent disease. Am J Clin Nutr. 1984; 40: 569–78
   PubMed Web of Science ®Google Scholar
• Sharman M., Read W. A., Castle L., Gilbert J. Levels of di-(2-ethylhexyl)phthalate and total phthalate esters in milk, cream, butter and cheese. Food Add Contam. 1994; 11: 375–85
   PubMed Web of Science ®Google Scholar
• Brotons J. A., Olea-Serrano M. F., Villalobos M., Pedraza V., Olea N. Xenooestrogens released from lacquer coatings in food cans. Environ Health Perspect. 1995; 103: 608–12
   PubMed Web of Science ®Google Scholar
• Olea N., Pulgar R., Perez P., et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 1996; 104: 298–305
   PubMed Web of Science ®Google Scholar
• Nimrod A. C., Benson W. H. Environmental estrogenic effects of alkylphenol ethoxylates. Crit Rev Toxicol. 1996; 26: 335–64
   PubMed Web of Science ®Google Scholar
• Lewis S. K., Lech J. J. Uptake, disposition, and persistence of nonylphenol from water in rainbow trout. (Oncorhynchus mykiss). Xenobiotica 1996; 26: 813–19
   PubMed Web of Science ®Google Scholar
• Dewailly E., Ayotte P., Bruneau S., Laliberte C., Muir DCG, Norstrom R. J. Inuit exposure to organochlorines through the aquatic food chain in Arctic Quebec. Environ Health Perspect. 1993; 101: 618–20
   PubMed Web of Science ®Google Scholar
• O'Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet. 1997; 349: 1161–6
   PubMed Web of Science ®Google Scholar
• Cooper R. I., Kavlok R. J. Endocrine disruptors and reproductive development: a weight-of-evidence overview. J Endocrinol 1997; 152: 159–66
   PubMed Web of Science ®Google Scholar
• Jacobs D. M., Tang M. X., Stern Y., et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998; 50: 368–73
   PubMed Web of Science ®Google Scholar
• Tang M. X., Jacobs D., Stern Y., et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429–32
   PubMed Web of Science ®Google Scholar
• Lu LJW, Anderson K. E., Grady J. J., Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women -implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prevention 1996; 5: 63–70
   PubMed Web of Science ®Google Scholar
• Cassidy A., Faughnan M., Hughes R., et al. Endocrine-modifying effects of phytoestrogens in postmenopausal women and elderly men. Am J Clin Nutr 1998, in press
   Web of Science ®Google Scholar
• Wilcox G., Wahlqvist M. L., Burger H. G., Medley G. Oestrogen effects of plant derived foods in postmenopausal women. Br Med J. 1990; 301: 905–6
   PubMed Web of Science ®Google Scholar
• Gavaler J. S., Van Thiel D. H., Galvao-Teles A. Oestrogenic responses in normal postmenopausal women to administration of the phytoestrogens in bourbon whiskey. Hepatology 1991; 14: 87
   Google Scholar
• Baird D. D., Umbach D. M., Lansdell L., et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1685–90
   PubMed Web of Science ®Google Scholar
• Murkies A. L., Lombard C., Strauss BJG, Wilcox G., Burger H. G., Morton M. S. Dietary flour supplementation decreases postmenopausal hot flushes - effect of soy and wheat. Maturitas. 1995; 21: 189–95
   PubMed Web of Science ®Google Scholar
• Brzezinski A., Adlercreutz H., Shaoul R., et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997; 4: 89–94
   Web of Science ®Google Scholar
• Albertazzi P., Pansini F., Bonaccorsi G., Zanotti L., Forini E., de Aloysio P. The effect of dietary soya supplementation on hot flushes. Obstet Gynecol. 1998; 91: 6–11
   PubMed Web of Science ®Google Scholar
• Sturdee D. W. Clinical symptoms of oestrogen deficiency. Curr Obstet Gynaecol. 1997; 7: 190–6
   Google Scholar
• Stampfer M. J., Colditz G. A., Willett W. C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N EnglJ Med 1991; 325: 756–62
   PubMed Web of Science ®Google Scholar
• Sarrel P. M. Ovarian hormones and the circulation. Maturitas. 1990; 12: 287–98
   PubMed Web of Science ®Google Scholar
• O'Brien T., Nguyen T. T. Lipids and lipoproteins in women. Mayo Clin Proc. 1997; 72: 235–44
   PubMed Web of Science ®Google Scholar
• Sirtori C. R., Even R., Lovati M. R. Soyabean diet and plasma cholesterol: from therapy to molecular mechanisms. Ann NY Acad Sci. 1993; 676: 188–201
   PubMed Web of Science ®Google Scholar
• Arjmandi B. H., Khan D. A., Juma S. S., Svanborg A. The ovarian hormone deficiency induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone. Nutr Res. 1997; 17: 885–94
   Web of Science ®Google Scholar
• Anthony M. S., Clarkson T. B., Hughes CL, Jr, Morgan T. M., Burke G. L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peri-pubertal rhesus monkeys. J Nutr 1996; 126: 43–50
   PubMed Web of Science ®Google Scholar
• Magness R. R., Rosenfield C. R. Local and systemic oestradiol 17β: effects on uterine and systemic vasodilation. AmJ Physiol. 1989; 256: E536–42
   PubMed Web of Science ®Google Scholar
• Farhat M. Y., Lavigne M. C., Ramwell P. W. The vascular protective effects of estrogen. FASEB J. 1996; 10: 615–24
   PubMed Web of Science ®Google Scholar
• Honore E. K., Williams J. K., Anthony M. S., Clarkson T. B. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997; 67: 148–54
   PubMed Web of Science ®Google Scholar
• Fotsis T., Peper M., Adlercreutz H., et al. Genistein, a dietary derived inhibitor of angio-genesis. Proc Natl Acad Sci, USA 1993; 90: 2690–4
   PubMed Web of Science ®Google Scholar
• Jaggers D. C., Collins W. P., Milligan S. R. Potent inhibitory effects of steroids in anin vitromodel of angiogenesis. J Endocrinol 1996; 150: 457–64
   PubMed Web of Science ®Google Scholar
• Sargeant P., Farndale R. W., Sage S. O. The tyrosine kinase inhibitors methyl 2,5-dihydroxy-cinnimate and genistein reduce thrombin-evoked tyrosine phophorylation and Ca2* entry in human platelets. FEBSLett. 1993; 315: 242–6
   PubMedGoogle Scholar
• Wilcox J. N., Blumenthal B. F. Thrombotic mechanisms in atherosclerosis: potential impactolsoyprotein J. Nutr 1995; 125: 631s–8s
   Web of Science ®Google Scholar
• Ruiz-Larrea M. B., Mohan A. R., Paganga G., Miller N. J., Bolwell G. P., Rice-Evans C. A. Antioxidant activity of phytoestrogenic isoflavones. Free Rad Res. 1997; 26: 63–70
   PubMed Web of Science ®Google Scholar
• Tobias J. H., Cook D. G., Chambers T. J., Dalzell N. A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci. 1994; 87: 587–91
   PubMed Web of Science ®Google Scholar
• Ho S. C. Body measurements, bone mass and fractures - does the Easter differ from the West?. Clin Orthop 1996; 323: 75–80
   PubMedGoogle Scholar
• Kao P. C., P'eng FK. How to reduce the risk factors of osteoporosis in Asia. Chung Hua I Hsueh Tsa Chih Taipei. 1995; 55: 209–13
   Google Scholar
• Anderson J. J., Ambrose W. W., Garner S. C. Orally dosed genistein from soy and prevention of cancellous bone loss in two ovarectomised rat models (Abstract). J Nutr 1995; 125: 799
   Google Scholar
• Arjmandi B. H., Alekel L., Hollis B. W., et al. Dietary soybean protein prevents bone loss in an ovarectomised rat model of osteoporosis. JNutr 1996; 126: 161–7
   Web of Science ®Google Scholar
• Tsutsumi N., Kawashima K., Nagata H., Ujiie A., Endo H. Effects of KCA-012 on bone metabolism in organ culture. Jpn J Pharmacol 1995; 67: 169–71
   PubMedGoogle Scholar
• Yoshida K., Tsukamoto T., Torii H., et al. Metabolism of ipriflavone TC-80; in rats. Radioisotopes 1985; 34: 612–17
   PubMedGoogle Scholar
• Cheng S. L., Zhang S. F., Nelson T. L., Warlow P. M., Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int. 1994; 55: 356–62
   PubMed Web of Science ®Google Scholar
• Brandi M. L. New treatment strategies: ipriflavone, strontium, vitamin D metabolites and analogs. Am J Med. 1993; 95(suppl 5A)69S–74S
   PubMedGoogle Scholar
• Melis G. B., Paoletti A. M., Bartolini R., et al. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium. Bone Miner 1992; 19(Suppl 1)S49–56
   PubMedGoogle Scholar
• Blair H. C., Jordan S. E., Peterson T. G., Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction in bone loss in ovarectomised rats. J Cell Biochetn. 1996; 61: 630–7
   Google Scholar
• Manolagas S. C., Jilka R. Bone marrow, cytokines and bone remodelling. N Engl J Med. 1995; 332: 305–11
   PubMed Web of Science ®Google Scholar
• Erdman J. W., Stillman R. J., Lee K. F. Short-term effects of soybean isoflavones on bone in postmenopausal women. Am J Clin Nutr 1998, in press
   Web of Science ®Google Scholar
• Pansini F., Bonaccorsi G., Albertazzi P., et al. Soy phytoestrogens and bone. Presented at theProceedings of North American Menopause Society. 1997, abstr 44
   Google Scholar
• Colerangle J. B., Roy D. Exposure of environmental estrogenic compound nonylphenol to Nobel rat alters cell cycle kinetics in the mammary gland. Endocrine. 1996; 4: 115–22
   PubMed Web of Science ®Google Scholar
• Hunter D. J., Hankinson S. E., Laden F., et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997; 337: 1253–8
   PubMed Web of Science ®Google Scholar
• Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 1997; 350: 990–4
   PubMed Web of Science ®Google Scholar
• Petrakis N. L., Barnes S., King E. B., et al. Stimulatory influence of soy protein isolate on breast secretion in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prevention 1996; 5: 785–94
   PubMed Web of Science ®Google Scholar
• Henderson B. E., Ross R. K., Judd H. L., Krailo M. D., Pike M. C. Do regular ovulatory cycles increase breast cancer risk?. Cancer 1985; 56: 1206–8
   PubMed Web of Science ®Google Scholar
• Ferguson DJP, Anderson T. J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the ‘resting’ human breast. Br J Cancer. 1981; 44: 177–81
   PubMed Web of Science ®Google Scholar
• Anderson T. J., Ferguson DJP, Raab G. M. Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterality. BrJ Cancer. 1982; 46: 376–82
   PubMed Web of Science ®Google Scholar